Xarelto News

Bayer and J&J subsidiary Janssen Pharmaceuticals decided to end the phase 3 NAVIGATE ESUS study of Xarelto after they got some bad news – the anticoagulant was no more effective than aspirin in preventing stroke and systemic embolism, and came with a much higher risk […]

According to the Institute for Safe Medication Practices’ QuarterWatch, an organization that monitors drug safety trends new oral anticoagulants (NOAC drugs), Pradaxa, Eliquis and Xarelto problems have earned them the title of 2016’s highest priority drug safety problem.These NOAC drugs cause bleeding injuries in 8% […]

Despite a last ditch effort by the defendants to avoid another trip to court, Dora Mingo, who experienced a serious Xarelto bleeding event, will see her day in court.  The Honorable Eldon E. Fallon,  Eastern District of Louisiana, ruled in favor of the plaintiffs last […]

A family suing Boehringer Ingelheim for wrongful death as a result of uncontrollable bleeding that was attributed to Pradaxa would like the Massachusetts Federal court to take into account the record of Boeheringer’s misconduct in earlier Pradaxa cases. Two years ago, Boehringer Ingelheim agreed to […]

A Virginia woman recently filed a Xarelto law suit claiming that her husband suffered serious injuries that led to his death as a result of use of Xarelto. The plaintiff seeks $2 million in damages. Xarelto Side Effects are very serious and have been previously […]

Since being introduced into the U.S. market in 2011, the blood thinner Xarelto is the subject of the Xarelto Lawsuit filed against drug maker Bayer AG and U.S. distributor Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson). Nearly 14,000 Xarelto lawsuit have been consolidated in […]

According to the Louisiana Record, over 9,000 Xarelto claims have been brought across the U.S. against the makers and distributors of the anticoagulant drug Xarelto, the majority centralized in multidistrict litigation (MDL) in the Eastern District of Louisiana under U.S. District Court Judge Eldon Fallon. Another 1,000 cases […]

Xarelto Risk is being tested in four bellwether Xarelto case involving plaintiffs who claim the drug caused uncontrolled bleeding events moving through the courts starting in February 2017. Xarelto bellwether trials are very important since they generally include a representative sample of all the cases […]

Portola Pharmaceuticals recently announced that the U.S. Food and Drug Administration (FDA) failed to approve AndexXa, the Xarelto antidote currently in development for uncontrollable bleeds. Currently, there is no reversal agent for uncontrolled bleeding associated with the anticoagulants Xarelto or Eliquis which have been linked […]

Side Effects Xarelto The side effects Xarelto story starts with initial approval in 2011, and the blood thinner has had an eventful journey, receiving several warnings from the U.S. Food and Drug Administration (FDA), as well as required labeling and advertising changes. July 2011 – […]